Nxera Pharma Co (FRA:JSS) FFO


FRA:JSS Nxera Pharma Co Ltd FRA:JSS
73 GF Score
Price €5.10
GF Value €6.99
! 7 Warning Signs
View Full Analysis

What is Nxera Pharma Co FFO?

FFO (Funds from operations) only applies to REITs.

FRA:JSS
73GF Score
Nxera Pharma Co Ltd FRA:JSS
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Nxera Pharma Co (FRA:JSS) Overvalued in 2026?

Based on GuruFocus' analysis, Nxera Pharma Co stock appears to be undervalued. The current stock price of €5.10 is trading 27% below its estimated GF Value™ of €6.99.

Key valuation signals for FRA:JSS:

  • FFO:
  • GF Value™: €6.99 vs. price of €5.10 (27% below fair value)
  • GF Score™: 73/100 with 7 warning signs

No single metric tells the full story. See the FRA:JSS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Nxera Pharma Co Business Description

Other Exchanges SOLTF:USA4565:Japan
Address Midtown East, 9-7-2 Akasaka Minato-ku, Tokyo, JPN, 107-0052
Nxera Pharma Co Ltd is a science and technology-led biopharmaceutical company. Its activities are drug discovery, drug development and the commercialization of pharmaceutical products. The focus is to discover new medicines for unmet medical needs, including novel small molecules, peptides and therapeutic antibodies targeting G Protein Coupled Receptors (GPCRs).
73GF Score

Get the complete analysis for FRA:JSS

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€5.10
Price
€6.99
GF Value